IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline

Eosinophils are not the sole contributor to asthma pathophysiology or lung function decline and emphasizes the need to block additional mediators to modify lung inflammation and impact lung function.